Get the Stockscreener App
148.79
0.47%
0.70
After Hours:
148.83
0.04
+0.03%
Overview
News
Price History
Option Chain
Financials
Why MS Down?
Discussions
Forecast
Stock Split
Dividend History
Morgan Stanley stock is traded at $148.79, with a volume of 3.82M.
It is up +0.47% in the last 24 hours and up +3.92% over the past month.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the great financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
See More
Previous Close:
$148.09
Open:
$148.32
24h Volume:
3.82M
Relative Volume:
0.75
Market Cap:
$237.52B
Revenue:
$109.29B
Net Income/Loss:
$14.90B
P/E Ratio:
16.85
EPS:
8.83
Net Cash Flow:
$20.03B
1W Performance:
-1.12%
1M Performance:
+3.92%
6M Performance:
+24.73%
1Y Performance:
+54.04%
1-Day Range:
$147.25
$149.20
1-Week Range:
$145.66
$151.86
52-Week Range:
$94.09
$151.86
Morgan Stanley Stock (MS) Company Profile
Name
Morgan Stanley
Sector
Industry
Phone
212-761-4000
Address
1585 BROADWAY, NEW YORK, NY
Compare MS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
148.79 | 236.40B | 109.29B | 14.90B | 20.03B | 8.83 |
|
GS
Goldman Sachs Group Inc
|
741.85 | 223.47B | 125.66B | 15.56B | 66.86B | 45.38 |
|
SCHW
Charles Schwab Corp
|
93.45 | 167.09B | 26.67B | 7.28B | 39.40B | 3.72 |
|
HOOD
Robinhood Markets Inc
|
117.28 | 89.98B | 3.59B | 1.79B | 876.00M | 0.96 |
|
LPLA
Lpl Financial Holdings Inc
|
340.52 | 26.64B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-24 | Downgrade | Goldman | Buy → Neutral |
| Aug-02-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-17-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-17-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Nov-20-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-23-23 | Downgrade | Odeon | Buy → Hold |
| Oct-20-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Oct-11-23 | Downgrade | UBS | Buy → Neutral |
| Sep-07-23 | Initiated | HSBC Securities | Buy |
| Jul-12-23 | Upgrade | Odeon | Hold → Buy |
| Jan-18-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-10-23 | Upgrade | Odeon | Sell → Hold |
| Jan-04-23 | Downgrade | Wolfe Research | Outperform → Underperform |
| Oct-05-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-06-22 | Downgrade | Odeon | Hold → Sell |
| May-03-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-22 | Downgrade | Odeon | Buy → Hold |
| Dec-03-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-04-21 | Reiterated | Jefferies | Buy |
| Sep-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-28-21 | Downgrade | Berenberg | Buy → Hold |
| Aug-13-21 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-09-21 | Initiated | Jefferies | Buy |
| Apr-21-21 | Upgrade | Berenberg | Hold → Buy |
| Mar-02-21 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-06-21 | Initiated | Daiwa Securities | Neutral |
| Jan-04-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-10-20 | Downgrade | Citigroup | Buy → Neutral |
| Oct-13-20 | Resumed | JP Morgan | Overweight |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jun-24-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-23-20 | Reiterated | UBS | Buy |
| May-21-20 | Upgrade | Odeon | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Buy |
| Mar-13-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-04-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-21-20 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-20-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-21-20 | Downgrade | Citigroup | Buy → Neutral |
| Jan-17-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-13-20 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-29-19 | Downgrade | Odeon | Buy → Hold |
| Oct-10-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jul-12-19 | Upgrade | Citigroup | Neutral → Buy |
| Apr-18-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Morgan Stanley Stock (MS) Latest News
Transcript : Amylyx Pharmaceuticals, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-08-2025 04 - MarketScreener
Medtronic at Morgan Stanley Conference: Strategic Growth Insights - Investing.com
Morgan Stanley resets GDP forecast for Q3 - TheStreet
Morgan Stanley’s Wilson: Market volatility could set stage for strong year-end rally - investingLive
NWS Offering Managed by Morgan Stanley - GuruFocus
Viking Therapeutics at Morgan Stanley Conference: Expanding Obesity Treatment Horizons - Investing.com
A New Bull Market Begins? - Morgan Stanley
Axsome Therapeutics at Morgan Stanley: Strategic Growth and Innovation - Investing.com
Merck & Co. at Morgan Stanley Conference: Diversification and Growth Prospects - Investing.com
Morgan Stanley ups its insurance game with athletes, retired boomers - financial-planning.com
Morgan Stanley raises $900m for Japan real estate fund as foreign investment surges - Alternatives Watch
Zoetis at Morgan Stanley Conference: Strategic Growth and Challenges - Investing.com
Jefferies taps Morgan Stanley for emerging markets credit trading director - The TRADE
CVS down 4% following presentation at Morgan Stanley investors conference - MSN
Morgan Stanley Discharges 25-Year Industry Vet, Cites ‘Differing Views’ - AdvisorHub
Schrödinger at Morgan Stanley Conference: Strategic Insights on Innovation - Investing.com
CVS Drops on Investor Worries About Government Ratings - Bloomberg.com
Samsara stock price target raised to $53 by Morgan Stanley on strong growth - Investing.com Nigeria
Ardelyx at Morgan Stanley Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Morgan Stanley Real Estate Arm Raises $900M for Japan-Focused Fund - USA Herald
Morgan Stanley believes this new exchange play has nearly 70% upside - CNBC
Morgan Stanley upgrades Sanofi stock rating to Overweight on growth outlook - Investing.com Nigeria
Morgan Stanley Raises $900M For Japan Real Estate Fund - Law360
Morgan Stanley initiates coverage on Ashland stock with Equalweight rating By Investing.com - Investing.com Nigeria
Fed Rates Don't Need to Be 'Drastically' Lower, Morgan Stanley's Zentner Says - Forex Factory
RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025 - The Manila Times
Leading Medical Imaging Provider RadNet's Leadership Team to Present at Morgan Stanley Healthcare Conference - Stock Titan
As IPO market resurges, investment banks could be winners - TheStreet
Biogen at Morgan Stanley Conference: Strategic Shift in Focus - Investing.com
Form 424B2 MORGAN STANLEY - StreetInsider
Acadia at Morgan Stanley Conference: Strategic Growth Focus - Investing.com
Top analyst says you weren't crazy for thinking the economy felt worse than it looked the last 3 years. The 'rolling recession' just ended - Fortune
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC - StreetInsider
Ashland rated Equal-weight in new coverage by Morgan Stanley (ASH:NYSE) - Seeking Alpha
Is Broadcom’s $382 target too ambitious against Nvidia? - Rolling Out
Moderna at Morgan Stanley Conference: Strategic Path to Growth - Investing.com
GeneDx at Morgan Stanley Conference: Rare Disease Focus - Investing.com
Transcript : TransMedics Group, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-08-2025 10 - MarketScreener
Morgan Stanley Europe SE announces partial cancellation of securities - Investing.com
TransMedics at Morgan Stanley Conference: Ambitious Growth Plans - Investing.com
Eli Lilly at Morgan Stanley Conference: Oncology and Incretin Insights - Investing.com
Sanofi upgraded at Morgan Stanley on potential of amlitelimab vs. Dupixent - Seeking Alpha
Zimmer Biomet at Morgan Stanley Conference: Strategic Growth Insights - Investing.com
Tesla future tied to Musk, AI ambitions—Morgan Stanley - Investing.com
Regeneron at Morgan Stanley Conference: Strategic Pipeline Potential - Investing.com
Morgan Stanley Reduces PT on Figma (FIG) Stock - Yahoo Finance
Morgan Stanley Raises PT on DTE Energy (DTE) Stock - Yahoo Finance
Bristol-Myers Squibb at Morgan Stanley Conference: Strategic Insights - Investing.com
HLI Stock Maintained at Overweight by Morgan Stanley; Price Targ - GuruFocus
Morgan Stanley’s Mike Wilson: The recession happened, and many missed it - MSN
Oracle price target raised to $246 from $175 at Morgan Stanley - TipRanks
Morgan Stanley Stock (MS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):